CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · IEX Real-Time Price · USD
3.11
0.00 (0.16%)
Jul 7, 2022 10:02 AM EDT - Market open

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011
Net Income
-90-50.99-102.81-72.55-27.56-26.67-15.53-31.92243.99-23.9
Upgrade
Depreciation & Amortization
0.690.630.570.110.040.030.020.020.060.12
Upgrade
Share-Based Compensation
107.3210.477.014.922.472.491.290.890.08
Upgrade
Other Operating Activities
9.88-1.7-6.1410.492.970.82-10.39.49-253.412.41
Upgrade
Operating Cash Flow
-69.43-44.73-97.91-54.94-19.63-23.35-23.32-21.11-8.46-11.29
Upgrade
Capital Expenditures
-0.09-0.02-0.32-0.53-0.03-0.040-0.10.660
Upgrade
Change in Investments
48.6847.98-34.03-53.58-67.527.17-11.08-16.84-6.8911.01
Upgrade
Investing Cash Flow
48.5947.96-34.35-54.11-67.5327.13-11.08-16.94-6.2311.01
Upgrade
Share Issuance / Repurchase
70.720.09108.13141.64102.86025.825.4826.510
Upgrade
Debt Issued / Paid
47.7400-6.65-3.14-0.994.73-0.244.85-0.01
Upgrade
Other Financing Activities
00000000-00
Upgrade
Financing Cash Flow
118.460.09108.13134.9999.72-0.9930.5325.2431.36-0.01
Upgrade
Net Cash Flow
97.613.32-24.1325.9412.562.79-3.88-12.8216.68-0.3
Upgrade
Free Cash Flow
-69.52-44.75-98.23-55.47-19.66-23.4-23.32-21.22-7.8-11.29
Upgrade
Free Cash Flow Margin
-----196.59%-----370.26%
Upgrade
Free Cash Flow Per Share
-0.98-0.65-1.47-0.96-0.56-1.00-1.23-1.76-3.31-1.00
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).